Gründerfonds Ruhr is a private venture capital fund driving innovation in the Ruhr area by investing in new technologies impacting a broad range of industries. We deploy the capital, the business expertise and the industry access from leading international corporations who share our goal of building Ruhr-based start-ups with transforming ideas. Our objective is to be the institutional investor of choice for founders and become a trusted partner with the resources to catapult young companies to their next stage of development and commercial success. Our long-term vision is to thereby boost entrepreneurial spirit in our region.
Key sectors include chemicals & new materials, energy & industrial sector, life sciences & healthcare, logistics & retail and the digital economy.
Our current portfolio consists of Abalos Therapeutics, DIMATE, Emergence Therapeutics, Fasciotens, Masterplan.com and talpasolutions.
For further information: www.gruenderfonds-ruhr.com
Company Details
- Employees
- 14
- Address
- Jakob-Funke Platz 2, Essen,north Rhine-Westphalia 45127,germany
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- Chemie & neue Werkstoffe, Energie & Industrie, Life Science & Gesundheit, Logistik & Handel, Digitale Wirtschaft.
- HQ
- Essen, North Rhine-Westphalia
Gründerfonds Ruhr Questions
Gründerfonds Ruhr's website is http://www.gruenderfonds-ruhr.com/
Gründerfonds Ruhr's LinkedIn profile is https://de.linkedin.com/company/gr%C3%BCnderfondsruhr
Gründerfonds Ruhr has
14 employees.
View email and phone details for 14
employees at Gründerfonds Ruhr.
Gründerfonds Ruhr's industry is
Venture Capital and Private Equity Principals
Gründerfonds Ruhr's top competitors are
Rag-Stiftung,
Ecapital Entrepreneurial Partners,
Cusp Capital,
Bryck.com,
Ruhrhub,
Htgf | High-Tech Gründerfonds,
Bryck Startup Alliance,
Better Ventures,
Nrw.bank,
Lidrotec.
Gründerfonds Ruhr's categories are Venture Capital and Private Equity Principals
